Laurion Capital Management LP Abeona Therapeutics Inc. Transaction History

Laurion Capital Management LP

  • $5.37 Billion
  • Q3 2025

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
SELL
$4.18 - $7.0 $4.31 Million - $7.21 Million
-1,030,674 Reduced 78.88%
275,915 $1.57 Million
Q3 2024

Nov 14, 2024
SELL
$4.12 - $6.32 $824,786 - $1.27 Million
-200,191 Reduced 13.29%
1,306,589 $8.26 Million
Q2 2024

Aug 14, 2024
BUY
$3.17 - $8.05 $2.73 Million - $6.92 Million
859,950 Added 132.95%
1,506,780 $6.39 Million
Q1 2024

May 15, 2024
BUY
$4.07 - $8.68 $2.63 Million - $5.61 Million
646,830 New
646,830 $4.69 Million

Others Institutions Holding ABEO

# of Institutions
108
Shares Held
32.9M
Call Options Held
1.34M
Put Options Held
271K
View Full List

About ABEONA THERAPEUTICS INC.

ABEO Quotes by TradingView
  • Ticker ABEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 5,950,380
  • Market Cap $26.5M
  • Description
  • Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-a...
More about ABEO
Track This Portfolio

Track Laurion Capital Management LP Portfolio

Follow Laurion Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Laurion Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email